Background Natriuretic peptides are frequently measured in patients with chronic cardiac failure (CCF). We set out to compare the variability of atrial natriuretic peptide (C-ANP) and its precursor N-terminal pro-ANP (Nt-proANP) to decide which would be more suitable for routine use.
|Number of pages||4|
|Journal||European Journal of Clinical Investigation|
|Publication status||Published - 2002|
ASJC Scopus subject areas